Abstract
Atorvastatin (ATV) exhibits pleiotropic effects on bone tissue and cardiovascular diseases, among others. Improving ATV's effectiveness requires enhancing its bioavailability, possibly through prolonged drug release. This study produced polycaprolactone/ATV nanocomposites through Hot Melting Extrusion (HME) at 69 °C. HME altered the crystallinity of both ATV and PCL. The resulting filament can be employed in 3D printing near the polymer's melting temperature, preventing ATV thermal degradation. ATV release is extended for both the filament and the produced scaffold (2mgATV/g scaffold). Results indicate this filament's potential as a valuable resource for 3D printing personalized products aimed at ATV release.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
